Brief: Checkpoint Therapeutics Announces Alignment With FDA
24/06/2024 12:36
June 24 (Reuters) - Checkpoint Therapeutics Inc
CKPT.O :
* CHECKPOINT THERAPEUTICS ANNOUNCES ALIGNMENT WITH FDA
ENABLING
UPCOMING COSIBELIMAB BLA RESUBMISSION
* CHECKPOINT: TO MOVE FORWARD WITH MID-YEAR BLA RESUBMISSION
SEEKING U.S. MARKETING APPROVAL FOR COSIBELIMAB
Source text for Eikon: ID:nGNX5jFbgt
Further company coverage: CKPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Checkpoint Therapeutics
See all newsCheckpoint Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Checkpoint Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Street View -India's Sun Pharma buying Checkpoint boosts its specialty portfolio, analysts say